The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Looking at Radiofrequency Ablation in Atrial Fibrillation
New research finds that people with atrial fibrillation (AF) who undergo radiofrequency ablation and maintain sinus rhythm are less likely than those who opt against the procedure to die of heart attack or heart failure.
How to Minimize Atrial Fibrillation after Electrical Cardioversion
Analysis of more than 5,000 successful electrical cardioversions performed without anticoagulation suggests that patients and doctors must act fast to minimize the chances that acute atrial fibrillation will lead to thromboembolic events.
Internists Differ from Cardiologists on Antiarrhythmic Strategies for Atrial Fibrillation
When managing patients with atrial fibrillation, internists use antiarrthymic strategies that significantly differ from those utilized by cardiologists, though both types of physicians similarly diverge from treatment guidelines.
Metformin Inappropriately Prescribed to Older Diabetics with Chronic Kidney Disease
July 28th 2014Clinicians must anticipate changes in kidney function during acute illness and surgical procedures, as well as frequently reassess metformin use in older patients, since kidney function declines predictably with age.
Steps to Minimize Serious Risks of Biologic Treatment for Autoimmune Disease
July 19th 2014Although tumor necrosis factor inhibitors have dramatically improved management strategies for autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease, the biologic agents also pose a number of significant side effects that physicians must consider.
Risk of New-onset Atrial Fibrillation Varies Across Antihypertensive Drug Classes
New research on the link between antihypertensive medications and atrial fibrillation suggests diuretics may trigger new cases of the condition, while angiotensin-converting enzymes may protect against it.